Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.
about
CCR5 monoclonal antibodies for HIV-1 therapyDual Function of Ccr5 during Langat Virus Encephalitis: Reduction in Neutrophil-Mediated Central Nervous System Inflammation and Increase in T Cell-Mediated Viral ClearanceNovel approaches and challenges to treatment of central nervous system viral infectionsWest Nile Virus: biology, transmission, and human infectionCould FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequenciesGenetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManTregs control the development of symptomatic West Nile virus infection in humans and miceMonoclonal antibody produced in plants efficiently treats West Nile virus infection in miceThe African diaspora: history, adaptation and healthArbovirus InfectionsAccelerated immunodeficiency by anti-CCR5 treatment in HIV infectionHuman genomics and preparedness for infectious threats.The CCR5Δ32 allele is not a major predisposing factor for severe H1N1pdm09 infection.The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population.Chemokine receptor 5 △32 allele in patients with severe pandemic (H1N1) 2009Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort studyGenetic Modulation Therapy Through Stem Cell Transplantation for Human Immunodeficiency Virus 1 Infection.Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins.The Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1.SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter.The role of chemokines during viral infection of the CNS.Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5.Host genetic risk factors for West Nile virus infection and disease progression.Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis.A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmissionPolymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian populationChemokine control of West Nile virus infection.Clinical use of CCR5 inhibitors in HIV and beyondCCR5: From Natural Resistance to a New Anti-HIV Strategy.Genetic variants and susceptibility to neurological complications following West Nile virus infection.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2.Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitisCCR5 limits cortical viral loads during West Nile virus infection of the central nervous system.The expression of the chemokine receptor CCR5 in tick-borne encephalitis.Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
P2860
Q22242739-F7EF99F7-7423-49CA-B744-B74B4FD678D9Q26700108-C36C313C-1F7B-4AB5-A4CD-3A7152F8F5D1Q26862449-091D2931-1B01-4133-A114-BBDC1ADA305BQ26865618-32E0FF45-BABC-445C-8B67-749BC588782BQ27487233-185705D4-6E7A-4B16-833E-0BF71799AA5BQ27487937-49C66F71-045E-4ADC-9AB8-18ED0C20A19AQ27490259-99C63A76-2BB0-4C58-8E28-FAC57912EE17Q27490937-EF345729-20DB-45B8-B42F-5B82DB585EFCQ28075805-ED69D59C-1DE8-4EBA-B326-1FE7D21AE1B7Q28081847-E8A829C5-04CA-4A81-B965-32013E12BB5AQ28475890-A1D58D34-66B9-49AA-91A1-A2A4E6B2AB03Q30227322-CAD44B76-F6BB-4838-9800-EE5FE9633A13Q30365474-51672D54-C041-44F9-ABD9-66CFAFD381C2Q30377320-BD6A97B0-7467-4C93-B70B-1198F5153998Q30394185-516CB133-A609-4419-992B-F8FD5E611826Q30409873-A057A9F1-591F-4471-969E-17BB916AFAE1Q31154829-0F7B1F5F-721F-43A3-95CD-E61BD84C05A0Q33352692-7D9DB4F8-50EE-4A78-9F43-A5D9C111AC70Q33563686-CA391277-BC51-4203-A0BD-8AE9F1B2B0BDQ33575393-F9AE5B6E-51BD-4DC4-9A86-1E6146C043CEQ33595068-C2D1F55A-D14D-45CF-943F-2761D0272FF5Q33613014-9F4C04F9-FE1E-484C-86BD-FA717B2EE19CQ33649710-D3CB1C76-2DB2-4876-85FD-C3E306A96E83Q33870421-38344267-BDE5-44E9-94AB-21579E0FCAC3Q34026212-363D2315-C36B-4AEB-90C8-E50FD70B8093Q34037579-56FD686C-823F-4891-AE03-269A9464D033Q34039347-8F1CA67A-086B-4AC6-B188-04135DA26497Q34108023-97D7C6E2-F886-4800-8040-1BA6A2D6D2EAQ34196240-962CF989-585E-485E-8562-AF6BB0892D47Q34632168-0BE9E0D2-290D-4342-8CFC-CCD12C1F1813Q35018145-99B1BB7E-66F6-4316-90FA-8FFE8B3B2FC2Q35260605-42221867-96E6-4321-A1DF-2F8009CD9890Q35466057-8719EB3F-6D02-4A1D-B218-D758F41CAA2FQ35531167-6D45F757-A96A-4953-8117-C427ABCF7F2FQ35620173-1A3D1ADE-1020-482C-B436-3E5FC7AE5F85Q35875096-92D42F9F-AACD-47C0-9B77-F0368B7C7CD2Q36109370-2A880D5E-4BDA-4DEF-B13D-3905E10E36E5Q36370470-16A64128-71CE-4265-9851-C9C667F0985EQ36606525-4A718E3B-E373-47EF-8CAA-6A968CD1C8D1Q37111827-A33BAD16-38DB-4F6C-8F42-EF5D8ED215A6
P2860
Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@ast
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@en
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@nl
type
label
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@ast
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@en
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@nl
prefLabel
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@ast
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@en
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@nl
P2093
P2860
P921
P356
P1476
Genetic deficiency of chemokin ...... 4 cohorts in the US epidemic.
@en
P2093
Bernard Johnson
Carol Glaser
Christine Y Louie
Cynthia Jean
Hope Johnson
Jean K Lim
P2860
P304
P356
10.1086/524691
P407
P577
2008-01-01T00:00:00Z